Protara Therapeutics (TARA) Receivables - Other (2014 - 2019)
Protara Therapeutics' (TARA) quarterly Receivables - Other came in at -$7000.0 in Q4 2019, up 86.54% year-on-year from -$3752.6 in Q4 2018, and down 40.0% on a QoQ basis from -$5000.0 in Q3 2019.
Protara Therapeutics (TARA) Receivables - Other (2014 - 2019) Analysis & Trends
Protara Therapeutics (TARA) has 6 years of Receivables - Other data on file, last reported at -$7000.0 in Q4 2019.
- On a quarterly basis, Receivables - Other rose 86.54% year-over-year to -$7000.0 in Q4 2019; TTM through Dec 2019 was -$17000.0, a 65.31% increase from a year earlier, with the FY2019 full-year figure at -$17000.0, up 65.31% from the prior year.
- Receivables - Other for Q4 2019 stood at -$7000.0, down from -$5000.0 in the prior quarter.
- Over the last five years, Receivables - Other for TARA reached as high as $305000.0 in Q1 2015 and fell as low as -$182000.0 in Q4 2015.
- Historically, Receivables - Other has averaged $2111.1 across 5 years, with a median of -$3500.0 in 2017.
- On a YoY basis, Receivables - Other climbed as much as 2133.33% in 2015 and fell as far as 768.75% in 2015.
- Year by year, Receivables - Other stood at -$182000.0 in 2015, then surged by 139.56% to $72000.0 in 2016, then slumped by 137.5% to -$27000.0 in 2017, then sank by 92.59% to -$52000.0 in 2018, then surged by 86.54% to -$7000.0 in 2019.
- Per Business Quant data, the three most recent Receivables - Other figures were -$7000.0 in Q4 2019, -$5000.0 in Q3 2019, and -$20000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protara Therapeutics | 233.61 Mn | 233.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -7,000.00 |
| Dec 31, 2019 | -7,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Jun 30, 2017 | -3,000.00 |
| Jun 30, 2017 | -3,000.00 |